Breast Cancer Clinical Trial
Official title:
BC-DAISY: A Breast Cancer Decision Aid System
The purpose of this study is to develop a web-based decision aid to help women at high risk for breast cancer make informed breast cancer prevention choices. These choices include chemoprevention, surgery, genetic counseling, or regular screening in accordance with recommended guidelines.
Decisions about breast cancer are complex and preference-based. Existing decision aids that
help identify women eligible for tamoxifen based on their breast cancer risk, such as the
Breast Cancer Risk Assessment Tool (BCRAT), were not designed to identify women's risks for
side-effects, her preferences for outcomes affected by treatment, nor the net balance of
benefits and risks. It is possible to predict the risks of side effects of treatments
according to patient characteristics, using patient-specific models.Our goal is to develop a
decision aid, TXplore, that rates the overall benefit:risk profiles of various breast cancer
prevention strategies according to a woman's risks for breast cancer, side-effects, and
preferences. Each user will receive a customized report card grading each available
prevention option, using preference-weighted risk:benefit grades; users can also explore
personalized feedback from the program. Our hypotheses are that this tool can improve the
implementation of appropriate prevention strategies, promote risk reduction behavior, and
improve PCP's ability to identify and counsel high risk women.We propose building on
modeling techniques that link the benefits and risks of preventive strategies to patient
characteristics and preferences. We now seek to conduct focus groups and usability tests on
end-users to optimize the design of the prototype TXplore.
The Specific Aims are:
1. To optimize the design of TXplore by focus groups conducted among diverse high-risk
women and PCPs to a) identify the domains driving decisions about prevention and
explore the framing of questions comparing the relative importance of one domain to
another, synthesizing this information as preference trade-off questions; and b)
explore the framing of risk:benefit grades and personalized feedback.
2. To assess the comprehensibility of preference trade-off questions by testing each
question on a diverse sample of 50 high-risk women, revising and retesting.
3. To assess the usability of TXplore for patients and PCPsThe successful completion of
this project will produce a novel tool for counseling women about their individual
benefits and risks of breast cancer prevention strategies. It will be the first tool of
its kind to integrate individual patient risks and preferences into decision support.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |